146 related articles for article (PubMed ID: 26712871)
1. FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.
Monaco SE; Rodriguez EF; Mahaffey AL; Dacic S
Am J Clin Pathol; 2016 Jan; 145(1):55-61. PubMed ID: 26712871
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of fibroblast growth factor receptor 1 gene locus amplification in resected lung squamous cell carcinoma.
Craddock KJ; Ludkovski O; Sykes J; Shepherd FA; Tsao MS
J Thorac Oncol; 2013 Nov; 8(11):1371-7. PubMed ID: 24077455
[TBL] [Abstract][Full Text] [Related]
3. Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.
Göke F; Franzen A; Menon R; Goltz D; Kirsten R; Boehm D; Vogel W; Göke A; Scheble V; Ellinger J; Gerigk U; Fend F; Wagner P; Schroeck A; Perner S
Chest; 2012 Oct; 142(4):1020-1026. PubMed ID: 22499828
[TBL] [Abstract][Full Text] [Related]
4. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.
Preusser M; Berghoff AS; Berger W; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckmann K; Wöhrer A; Hackl M; von Deimling A; Streubel B; Birner P
Lung Cancer; 2014 Jan; 83(1):83-9. PubMed ID: 24183471
[TBL] [Abstract][Full Text] [Related]
5. Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.
Young RJ; Lim AM; Angel C; Collins M; Deb S; Corry J; Wiesenfeld D; Kleid S; Sigston E; Lyons B; Russell PA; Wright G; McArthur GA; Fox SB; Rischin D; Solomon B
Oral Oncol; 2013 Jun; 49(6):576-81. PubMed ID: 23434054
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
8. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T
PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC).
Guo Q; Sun Y; Yu S; Bai H; Zhao J; Zhuo M; Wang J
Thorac Cancer; 2017 Mar; 8(2):73-79. PubMed ID: 28008744
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH.
Russell PA; Yu Y; Young RJ; Conron M; Wainer Z; Alam N; Solomon B; Wright GM
Mod Pathol; 2014 Dec; 27(12):1621-31. PubMed ID: 24762544
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
Elakad O; Lois AM; Schmitz K; Yao S; Hugo S; Lukat L; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Reuter-Jessen K; Schildhaus HU; Ströbel P; Bohnenberger H
Cancer Med; 2020 May; 9(10):3574-3583. PubMed ID: 32207251
[TBL] [Abstract][Full Text] [Related]
12. FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis.
Jiang T; Gao G; Fan G; Li M; Zhou C
Lung Cancer; 2015 Jan; 87(1):1-7. PubMed ID: 25433983
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.
Schröck A; Göke F; Wagner P; Bode M; Franzen A; Huss S; Agaimy A; Ihrler S; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
Head Neck; 2014 Sep; 36(9):1253-7. PubMed ID: 23913758
[TBL] [Abstract][Full Text] [Related]
14. FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.
Flockerzi FA; Roggia C; Langer F; Holleczek B; Bohle RM
Virchows Arch; 2018 May; 472(5):759-769. PubMed ID: 29270870
[TBL] [Abstract][Full Text] [Related]
15. FGFR1 amplification in squamous cell carcinoma of the lung.
Heist RS; Mino-Kenudson M; Sequist LV; Tammireddy S; Morrissey L; Christiani DC; Engelman JA; Iafrate AJ
J Thorac Oncol; 2012 Dec; 7(12):1775-1780. PubMed ID: 23154548
[TBL] [Abstract][Full Text] [Related]
16. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
[TBL] [Abstract][Full Text] [Related]
17. Association Between Fibroblast Growth Factor Receptor 1 Gene Amplification and Human Papillomavirus Prevalence in Tonsillar Squamous Cell Carcinoma With Clinicopathologic Analysis.
Park S; Lee M; Cho KJ; Kim SB; Roh JL; Choi SH; Nam SY; Kim SY; Song JS
J Histochem Cytochem; 2018 Jul; 66(7):511-522. PubMed ID: 29553868
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.
Lim SH; Sun JM; Choi YL; Kim HR; Ahn S; Lee JY; Lee SH; Ahn JS; Park K; Kim JH; Cho BC; Ahn MJ
Cancer; 2016 Oct; 122(19):3024-31. PubMed ID: 27315356
[TBL] [Abstract][Full Text] [Related]
19. Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.
Malchers F; Dietlein F; Schöttle J; Lu X; Nogova L; Albus K; Fernandez-Cuesta L; Heuckmann JM; Gautschi O; Diebold J; Plenker D; Gardizi M; Scheffler M; Bos M; Seidel D; Leenders F; Richters A; Peifer M; Florin A; Mainkar PS; Karre N; Chandrasekhar S; George J; Silling S; Rauh D; Zander T; Ullrich RT; Reinhardt HC; Ringeisen F; Büttner R; Heukamp LC; Wolf J; Thomas RK
Cancer Discov; 2014 Feb; 4(2):246-57. PubMed ID: 24302556
[TBL] [Abstract][Full Text] [Related]
20. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.
Seo AN; Jin Y; Lee HJ; Sun PL; Kim H; Jheon S; Kim K; Lee CT; Chung JH
Virchows Arch; 2014 Nov; 465(5):547-58. PubMed ID: 25086725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
